POC(Point of Care) 초음파 시장 : 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰, 예측(2026-2034년)

Growth Factors of point-of-care ultrasound (POCUS) Market

The global point-of-care ultrasound (POCUS) market was valued at USD 1.5 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 5.56 billion by 2034, registering a strong CAGR of 15.93% during the forecast period. The market growth is driven by rising demand for portable diagnostic imaging, increasing adoption in emergency and outpatient settings, and continuous technological advancements.

North America dominated the market in 2025, accounting for 39.43% share, supported by the high adoption of compact ultrasound devices and well-established healthcare infrastructure. The U.S. market is expected to witness significant growth, reaching USD 1.46 billion by 2032.

Market Trends

Shift Toward Portable and Hand-held Devices

A major trend shaping the market is the increasing preference for compact and hand-held ultrasound systems over traditional cart-based devices. Portable devices offer benefits such as affordability, ease of use, and real-time imaging at the patient's bedside.

Compared to conventional systems costing between USD 40,000 and USD 200,000, portable ultrasound devices are significantly more economical, ranging from USD 8,000 to USD 10,000. This cost advantage, combined with high efficiency and portability, is accelerating their adoption across hospitals, clinics, and homecare settings.

Market Growth Drivers

Rising Demand in Emergency and Outpatient Care

The global healthcare system is witnessing a shift from inpatient to outpatient care, increasing the need for quick and accurate diagnostic tools. POCUS devices enable immediate diagnosis and real-time imaging during emergency situations, making them essential in intensive care units, cardiology, and obstetrics.

Additionally, increasing prevalence of chronic diseases such as cardiovascular disorders and respiratory conditions is driving the demand for ultrasound imaging in early diagnosis and monitoring.

Technological Advancements and Product Launches

Key players are heavily investing in R&D to develop advanced ultrasound devices integrated with artificial intelligence (AI). These innovations enhance image quality, diagnostic accuracy, and workflow efficiency.

Recent product launches, including compact and AI-enabled ultrasound systems, have significantly improved clinical decision-making. The introduction of hand-held devices capable of connecting to smartphones has further expanded accessibility and adoption.

Restraining Factors

Limitations of Portable Devices and Skill Gaps

Despite strong growth, the market faces challenges such as limited imaging capabilities of hand-held devices compared to traditional systems. These devices may lack advanced features like 3D and 4D imaging, affecting diagnostic accuracy in complex cases.

Additionally, the lack of trained professionals and limited availability of certification programs for ultrasound usage restrict adoption, especially in developing regions. Insufficient awareness and training infrastructure also hinder market growth.

Market Segmentation Analysis

By Product Type

The cart-based ultrasound segment dominated the market with 67.33% share in 2026, owing to its high imaging quality and extensive use in hospitals. However, the hand-held segment is expected to grow at a higher CAGR due to rising demand for portable and cost-effective solutions.

By End User

The hospital segment is projected to hold the largest share of 63.18% in 2026, driven by increasing patient admissions in emergency and intensive care units. Meanwhile, the clinics segment is expected to grow rapidly due to expanding outpatient services and diagnostic facilities.

Regional Insights

North America

North America generated USD 0.59 billion in 2025 and is projected to reach USD 0.67 billion in 2026. Growth is driven by technological advancements, high healthcare spending, and increasing adoption of portable ultrasound devices.

Europe

Europe accounted for USD 0.39 billion in 2025, supported by rising diagnostic procedures and increasing prevalence of chronic diseases. The region continues to expand with improved healthcare infrastructure.

Asia Pacific

Asia Pacific reached USD 0.43 billion in 2025 and is expected to register the highest CAGR due to rising patient population, growing healthcare investments, and increasing awareness about early diagnosis.

Latin America & Middle East & Africa

These regions held smaller shares in 2025 but are expected to witness steady growth due to improving healthcare access and increasing adoption of diagnostic imaging technologies.

Key Market Players

The market is highly competitive with leading companies focusing on innovation and partnerships. Key players include:

• GE HealthCare
• Koninklijke Philips N.V.
• Siemens Healthineers
• FUJIFILM Sonosite, Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Butterfly Network, Inc.

These companies are expanding their product portfolios and investing in AI-enabled and portable ultrasound solutions to strengthen their market presence.

Conclusion

The global point-of-care ultrasound market is poised for significant growth, expanding from USD 1.5 billion in 2025 to USD 5.56 billion by 2034. The rising demand for portable, cost-effective, and real-time diagnostic tools, along with technological advancements, will continue to drive market expansion.

Segmentation By Product

• Cart-based
• Compact & Hand-held

By End user

• Hospitals
• Clinics
• Others

By Geography

• North America (By Product, End User, and Country)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, End User, and Country)
  • Germany (By Product)
  • France (By Product)
  • U.K. (By Product)
  • Italy (By Product)
  • Russia (By Product)
  • Rest of Europe (By Product)
• Asia Pacific (By Product, End User, and Country)
  • China (By Product)
  • Japan (By Product)
  • South Korea (By Product)
  • India (By Product)
  • Australia (By Product)
  • Taiwan (By Product)
  • Indonesia (By Product)
  • Thailand (By Product)
  • Malaysia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Product, End User, and Country)
  • Mexico (By Product)
  • Brazil (By Product)
  • Colombia (By Product)
  • Argentina (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, End User, and Country)
  • Turkey (By Product)
  • Saudi Arabia (By Product)
  • UAE (By Product)
  • Rest of Middle East & Africa (By Product)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of Emergency Department (ED) Visits, By Key Countries, 2025/ 2026
• 4.2. Evolution of Ultrasound Technology
• 4.3. New Product Launches, By Key Players
• 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
• 4.5. Impact of COVID-19 on the Market

5. Global Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 5.1.1. Cart Based
  • 5.1.2. Compact & Hand-held
• 5.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 5.2.1. Hospitals
  • 5.2.2. Clinics
  • 5.2.3. Others
• 5.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East and Africa

6. North America Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 6.1.1. Cart Based
  • 6.1.2. Compact & Hand-held
• 6.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 6.2.1. Hospitals
  • 6.2.2. Clinics
  • 6.2.3. Others
• 6.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
    • 6.3.1.1. By Product
  • 6.3.2. Canada
    • 6.3.2.1. By Product

7. Europe Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 7.1.1. Cart Based
  • 7.1.2. Compact & Hand-held
• 7.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 7.2.1. Hospitals
  • 7.2.2. Clinics
  • 7.2.3. Others
• 7.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. U.K.
    • 7.3.1.1. By Product
  • 7.3.2. Germany
    • 7.3.2.1. By Product
  • 7.3.3. France
    • 7.3.3.1. By Product
  • 7.3.4. Italy
    • 7.3.4.1. By Product
  • 7.3.5. Russia
    • 7.3.5.1. By Product
  • 7.3.6. Rest of Europe
    • 7.3.6.1. By Product

8. Asia Pacific Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 8.1.1. Cart Based
  • 8.1.2. Compact & Hand-held
• 8.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 8.2.1. Hospitals
  • 8.2.2. Clinics
  • 8.2.3. Others
• 8.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Country/Sub-region
  • 8.3.1. China
    • 8.3.1.1. By Product
  • 8.3.2. Japan
    • 8.3.2.1. By Product
  • 8.3.3. South Korea
    • 8.3.3.1. By Product
  • 8.3.4. India
    • 8.3.4.1. By Product
  • 8.3.5. Australia
    • 8.3.5.1. By Product
  • 8.3.6. Taiwan
    • 8.3.6.1. By Product
  • 8.3.7. Indonesia
    • 8.3.7.1. By Product
  • 8.3.8. Thailand
    • 8.3.8.1. By Product
  • 8.3.9. Malaysia
    • 8.3.9.1. By Product
  • 8.3.10. Rest of Asia Pacific
    • 8.3.10.1. By Product

9. Latin America Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 9.1.1. Cart Based
  • 9.1.2. Compact & Hand-held
• 9.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 9.2.1. Hospitals
  • 9.2.2. Clinics
  • 9.2.3. Others
• 9.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Country/Sub-region
  • 9.3.1. Brazil
    • 9.3.1.1. By Product
  • 9.3.2. Mexico
    • 9.3.2.1. By Product
  • 9.3.3. Colombia
    • 9.3.3.1. By Product
  • 9.3.4. Argentina
    • 9.3.4.1. By Product
  • 9.3.5. Rest of Latin America
    • 9.3.5.1. By Product

10. Middle East & Africa Point-of-care Ultrasound Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Product
  • 10.1.1. Cart Based
  • 10.1.2. Compact & Hand-held
• 10.2. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By End User
  • 10.2.1. Hospitals
  • 10.2.2. Clinics
  • 10.2.3. Others
• 10.3. Market Revenue (USD Billion) and Volume (Units) Analysis, Insights and Forecast - By Country/Sub-region
  • 10.3.1. Turkey
    • 10.3.1.1. By Product
  • 10.3.2. Saudi Arabia
    • 10.3.2.1. By Product
  • 10.3.3. UAE
    • 10.3.3.1. By Product
  • 10.3.4. Rest of Middle East & Africa
    • 10.3.4.1. By Product

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. GE Healthcare
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Koninklijke Philips N.V.
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. FUJIFILM Sonosite, Inc.
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. ALPINION MEDICAL SYSTEMS Co., Ltd.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Hitachi Healthcare Americas (FUJIFILM Holdings Corporation)
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. EDAN Instruments, Inc.
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. TERASON DIVISION TERATECH CORPORATION
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. CHISON Medical Technologies Co., Ltd.
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Healcerion Co., Ltd.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. Butterfly network Inc.
    • 11.2.11.1. Overview
    • 11.2.11.2. Products & Services
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)
  • 11.2.12. Becton Dickson and Company
    • 11.2.12.1. Overview
    • 11.2.12.2. Products & Services
    • 11.2.12.3. SWOT Analysis
    • 11.2.12.4. Recent Developments
    • 11.2.12.5. Strategies
    • 11.2.12.6. Financials (Based on Availability)
  • 11.2.13. Zimmer
    • 11.2.13.1. Overview
    • 11.2.13.2. Products & Services
    • 11.2.13.3. SWOT Analysis
    • 11.2.13.4. Recent Developments
    • 11.2.13.5. Strategies
    • 11.2.13.6. Financials (Based on Availability)
  • 11.2.14. Teknova Medical Systems
    • 11.2.14.1. Overview
    • 11.2.14.2. Products & Services
    • 11.2.14.3. SWOT Analysis
    • 11.2.14.4. Recent Developments
    • 11.2.14.5. Strategies
    • 11.2.14.6. Financials (Based on Availability)
  • 11.2.15. Advanced Instrumentations
    • 11.2.15.1. Overview
    • 11.2.15.2. Products & Services
    • 11.2.15.3. SWOT Analysis
    • 11.2.15.4. Recent Developments
    • 11.2.15.5. Strategies
    • 11.2.15.6. Financials (Based on Availability)
  • 11.2.16. DRE Medical
    • 11.2.16.1. Overview
    • 11.2.16.2. Products & Services
    • 11.2.16.3. SWOT Analysis
    • 11.2.16.4. Recent Developments
    • 11.2.16.5. Strategies
    • 11.2.16.6. Financials (Based on Availability)
  • 11.2.17. DRAMINSKI S. A.
    • 11.2.17.1. Overview
    • 11.2.17.2. Products & Services
    • 11.2.17.3. SWOT Analysis
    • 11.2.17.4. Recent Developments
    • 11.2.17.5. Strategies
    • 11.2.17.6. Financials (Based on Availability)
  • 11.2.18. Shenzhen Landwind Industry Co., Ltd
    • 11.2.18.1. Overview
    • 11.2.18.2. Products & Services
    • 11.2.18.3. SWOT Analysis
    • 11.2.18.4. Recent Developments
    • 11.2.18.5. Strategies
    • 11.2.18.6. Financials (Based on Availability)
  • 11.2.19. Clarius
    • 11.2.19.1. Overview
    • 11.2.19.2. Products & Services
    • 11.2.19.3. SWOT Analysis
    • 11.2.19.4. Recent Developments
    • 11.2.19.5. Strategies
    • 11.2.19.6. Financials (Based on Availability)